December 6, 2019

December 06, 2019

Subscribe to Latest Legal News and Analysis

December 05, 2019

Subscribe to Latest Legal News and Analysis

December 04, 2019

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
6
Dec
Illinois Governor Signs Employer-Friendly Amendments to Recreational Marijuana Law Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
6
Dec
Feds Issue Badly Needed Hemp and CBD Banking Guidance Wilson Elser Moskowitz Edelman & Dicker LLP
6
Dec
Iowa Governor Demonstrates Further Support For The Biofuels Industry Bergeson & Campbell, P.C.
6
Dec
Drug and Alcohol Testing Policy Check-Up – Are You Ready for 2020? Jackson Lewis P.C.
6
Dec
Scientists Uncover Production Of Aromatic Alcohols From Lignocellulosic Biomass Bergeson & Campbell, P.C.
6
Dec
USDA Finalizes Rule For SNAP Requirements for Able-Bodied Adults Without Dependents Keller and Heckman LLP
5
Dec
FDA Issues Swiss Company a Temporary Permit to Market “Ruby Chocolate” in the United States Keller and Heckman LLP
5
Dec
TCPA Class Melts Under Sweltering Scrutiny: Company-Wide Training Policy and Plaintiff’s “Distressing” Ignorance of Her Claim Against Ice Cream Company Defeats Typicality and Adequacy Squire Patton Boggs (US) LLP
5
Dec
Evolution & Revolution: Device Policy Priorities at FDA in 2019 Mintz
5
Dec
Researchers Find Nanotoxicity Studies May Be Affected by Nanoparticles Staying Behind in Syringes Bergeson & Campbell, P.C.
4
Dec
Year-End State Law Roundup: Get Ready for 2020! (US) Squire Patton Boggs (US) LLP
4
Dec
What to Know About FDA’s Recent Statements on CBD McDermott Will & Emery
4
Dec
Gov. Evers Signs Hemp 2.0 Bill von Briesen & Roper, s.c.
4
Dec
Proposed Class Action Alleges Company’s CBD Products Violate Federal Law Keller and Heckman LLP
3
Dec
ECHA Releases New, Updated Guidance Documents for Registering Nanoform Substances Bergeson & Campbell, P.C.
3
Dec
Less Than One Month until California Online Ingredients Disclosure Requirements in Effect for Designated Cleaning Products Bergeson & Campbell, P.C.
3
Dec
Governor Evers Signs Legislation Advancing Wisconsin Hemp Regulation Godfrey & Kahn S.C.
3
Dec
Private Eyes: When is Company Information Shared with the CPSC Confidential? Schiff Hardin LLP
3
Dec
China Solicits Comments on Food-Contact Substances Keller and Heckman LLP
3
Dec
After Decades of Broad Enforcement Discretion, FDA Signals New Approach to Homeopathic Drugs Epstein Becker & Green, P.C.

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS